Publicações Científicas 2024 - Abril


1. Afonso J, Barbosa-Matos C, Silvestre R, Pereira-Vieira J, Gonçalves SM, Mendes-Alves C, et al. Cisplatin-Resistant Urothelial Bladder Cancer Cells Undergo Metabolic Reprogramming beyond the Warburg Effect. Cancers (Basel). 2024;16(7). 10.3390/cancers16071418.


2. Aguiar Freitas AJ, Nunes CR, Mano MS, Causin RL, Calfa S, de Oliveira MA, et al. Circulating microRNAs as potential biomarkers in triple-negative breast cancer: a translational research study of the NACATRINE trial. Future Oncol. 2024;20(1):25-38. 10.2217/fon-2023-0886.


3. Arantes L, Silva-Oliveira RJ, de Carvalho AC, Melendez ME, Sorroche BP, de Jesus Teixeira R, et al. Unveiling the role of MGMT and DAPK hypermethylation in response to anti-EGFR agents: Molecular insights for advancing HNSCC treatment. Head Neck. 2024;46(3):461-72. 10.1002/hed.27602.


4. Arias AV, Lintner-Rivera M, Shafi NI, Abbas Q, Abdelhafeez AH, Ali M, et al. A research definition and framework for acute paediatric critical illness across resource-variable settings: a modified Delphi consensus. Lancet Glob Health. 2024;12(2):e331-e40. 10.1016/s2214-109x(23)00537-5.


5. Arruda do Espirito Santo P, Meine GC, Baraldo S, Barbosa EC. Cold endoscopic mucosal resection versus cold snare polypectomy for colorectal lesions: a systematic review and meta-analysis of randomized controlled trials. Endoscopy. 2024. 10.1055/a-2275-5349.


6. Barbosa EC, Espírito Santo PA, Baraldo S, Meine GC. Remimazolam versus propofol for sedation in gastrointestinal endoscopic procedures: a systematic review and meta-analysis. Br J Anaesth. 2024. 10.1016/j.bja.2024.02.005.


7. Barbosa EC, Santo P, Baraldo S, Nau AL, Meine GC. EUS- versus ERCP-guided biliary drainage for malignant biliary obstruction: A systematic review and meta-analysis of randomized controlled trials. Gastrointest Endosc. 2024. 10.1016/j.gie.2024.04.019.


8. Bednar EM, Paiz KA, Lu KH, Soares Dias De Souza AP, Oliveira G, Andrade C, et al. Delivery of hereditary cancer genetics services to patients newly diagnosed with ovarian and endometrial cancers at three gynecologic oncology clinics in the USA, Brazil, and Mexico. Int J Gynecol Cancer. 2024. 10.1136/ijgc-2023-005190.


9. Borges CDJ, Alfonso Rodriguez Elvir F, Silva Santana L, Michaela de Oliveira H, Laura Lima Larcipretti A, Muniz Vieira de Melo T, et al. Asleep versus awake GPi DBS surgery for Parkinson’s disease: A systematic review and meta-analysis. J Clin Neurosci. 2024;123:196-202. 10.1016/j.jocn.2024.03.033.


10. Buralli R, Ribeiro A, Cremonese C, Vineis P, Meyer A. Cancer mortality and premature deaths among hairdressers in Brazil. Environ Res. 2024;244:117942. 10.1016/j.envres.2023.117942.


11. Campacci N, Grasel RS, Galvão HCR, Garcia LF, Ribeiro PC, Pereira K, et al. The history of families at-risk for hereditary breast and ovarian cancer: what are the impacts of genetic counseling and testing? Front Psychol. 2024;15:1306388. 10.3389/fpsyg.2024.1306388.


12. Cappellano AM, Dassi N, Mançano BM, Epelman S, Almeida DB, Cavalheiro S, et al. Intracranial non-germinomatous germ cell tumors in children and adolescents: how can the experience from an uppermiddle-income country contribute to the worldwide effort to improve outcomes? Front Oncol. 2024;14:1308128. 10.3389/fonc.2024.1308128.


13. Carvalho BF, Gomez GVB, Carron J, Macedo LT, Gonçalves GM, Vazquez VL, et al. TNFRSF1B Gene Variants in Clinicopathological Aspects and Prognosis of Patients with Cutaneous Melanoma. Int J Mol Sci. 2024;25(5). 10.3390/ijms25052868.


14. Carvalho L, de Lima FP, Cerqueira M, Silva A, Pontes O, Oliveira-Pinto S, et al. In vitro and in vivo evaluation of novel chromeno[2,3-d]pyrimidinones as therapeutic agents for triple negative breast cancer. RSC Med Chem. 2024;15(4):1362-80. 10.1039/d3md00682d.


15. Casali BC, Baptista MP, Pachane BC, Cortez AA, Altei WF, Selistre-de-Araújo HS. Blockage of αvβ3 integrin in 3D culture of triple-negative breast cancer and endothelial cells inhibits migration and discourages endothelial-to-mesenchymal plasticity. Biochem Biophys Rep. 2024;38:101686. 10.1016/j.bbrep.2024.101686.


16. Chavan R, Baraldo S, Patel N, Gandhi C, Rajput S. Technical tips for EUS-guided embolization of varices and pseudoaneurysms. VideoGIE. 2024;9(4):211-9. 10.1016/j.vgie.2023.12.006.


17. Chavan R, Baraldo S, Rajput S. Inclusion of Patients With Duodenal Obstruction in Endoscopic Retrograde Cholangiopancreatography Group: Not a Right Intention. Gastroenterology. 2024;166(1):215. 10.1053/j.gastro.2023.05.011.


18. Custódio IDD, Nunes FSM, Lima MTM, Carvalho KP, Machado AM, Lajolo PP, et al. Health-Related quality of life by 31-item Cervantes scale in breast cancer survivors undergoing adjuvant endocrine therapy. Clinics (Sao Paulo). 2024;79:100324. 10.1016/j.clinsp.2024.100324.


19. da Costa Vieira RA, Facina G, Tiezzi DG, Urban CA, de Freitas Junior R. Editorial: Oncoplastic surgery for breast cancer. Front Oncol. 2023;13:1348964. 10.3389/fonc.2023.1348964.


20. de Arruda JAA, Oliveira SR, Heimlich FV, de Amorim-Santos BM, Schneider AH, de Sena A, et al. Kinetics of neutrophil extracellular traps and cytokines in oral mucositis and Candida infection. Oral Dis. 2024. 10.1111/odi.14857.


21. De Marchi P, Leal LF, da Silva LS, Cavagna RO, da Silva FAF, da Silva VD, et al. Gene expression profiles (GEPs) of immuno-oncologic pathways as predictors of response to checkpoint inhibitors in advanced NSCLC. Transl Oncol. 2024;39:101818. 10.1016/j.tranon.2023.101818.


22. Diniz JBC, Alfonso Rodriguez Elvir F, Silva Santana L, Batista S, Glioche Gasparri L, Mota Telles JP, et al. Replacement of traditional vagus nerve stimulation with cardiac-based device and seizure reduction: A systematic review and meta-analysis. Seizure. 2024;118:65-70. 10.1016/j.seizure.2024.04.001.


23. Eskelinen M, Meklin J, Guimaraes DP, Selander T, Syrjänen K, Eskelinen M. The Diagnostic Accuracy (DA) of ColonView Fecal Immunochemical Test (FIT) in Detecting Colorectal Adenoma (CRA) Can Be Improved by the Diagnostic Models (DM) that Include Triage and Risk Features of CRA. Anticancer Res. 2024;44(1):173-84. 10.21873/anticanres.16800.


24. Ferreira J, Afonso J, Longatto-Filho A, Roque S, Carneiro A, Vila I, et al. Inflammation Is a Histological Characteristic of Skeletal Muscle in Chronic Limb Threatening Ischemia. Ann Vasc Surg. 2024;99:10-8. 10.1016/j.avsg.2023.09.094.


25. Ferreira J, Longatto-Filho A, Afonso J, Roque S, Carneiro AL, Vila I, et al. Inflammatory Cells in Adipose Tissue and Skeletal Muscle of Patients with Peripheral Arterial Disease or Chronic Venous Disease: A Prospective, Observational, and Histological Study. J Cardiovasc Dev Dis. 2024;11(4). 10.3390/jcdd11040121.


26. Ferreira J, Longatto-Filho A, Dionísio A, Correia-Neves M, Cunha P, Mansilha A. Peri-Carotid Adipose Tissue and Atherosclerosis at Carotid Bifurcation. J Cardiovasc Dev Dis. 2024;11(2). 10.3390/jcdd11020058.


27. Ferreira J, Roque S, Lima Carneiro A, Longatto-Filho A, Vila IN, Cunha C, et al. Reversion of the Inflammatory Markers in Patients With Chronic Limb-Threatening Ischemia. J Am Heart Assoc. 2024;13(8):e031922. 10.1161/jaha.123.031922.


28. Ferreira MY, Thomaz de Assis EB, Batista S, Palavani LB, Verly G, Corrêa EM, et al. Survival Impact of Combined Biguanide and Temozolomide in Glioblastoma Preclinical Models: A Systematic Review and Meta-Analysis. World Neurosurg. 2024. 10.1016/j.wneu.2024.01.006.


29. Fontes MS, de Almeida DVP, Cárcano F, Lages P, Dienstmann R. Precision medicine for urothelial carcinoma: An international perspective. Urol Oncol. 2024. 10.1016/j.urolonc.2023.11.008.


30. Garcia ALH, de Souza MR, Picinini J, Soares S, Rohr P, Linden R, et al. Unraveling gene expression and genetic instability in dental fluorosis: Investigating the impact of chronic fluoride exposure. Sci Total Environ. 2024;906:167393. 10.1016/j.scitotenv.2023.167393.


31. Gouveia AG, Viani GA, Bratti VF, Marta GN, Hanna SA, Jacinto AA, et al. Challenges in building radiotherapy capacity: A longitudinal study evaluating eight years of the Brazilian radiotherapy expansion plan. J Cancer Policy. 2024;39:100459. 10.1016/j.jcpo.2023.100459.


32. Groisman Sieben R, Paternina-de la Ossa R, Waack A, Casale Aragon D, Bellissimo-Rodrigues F, Israel do Prado S, et al. Risk factors and mortality of candidemia in a children’s public hospital in Sao Paulo, Brazil. Rev Argent Microbiol. 2024. 10.1016/j.ram.2023.09.002.


33. Guimarães Ribeiro A, Ferlay J, Vaccarella S, Dias de Oliveira Latorre MDR, Tavares Guerreiro Fregnani JH, Bray F. Ethnic disparities in cancer mortality in the capital and northeast of the State of São Paulo, Brazil 2001-17. Cancer Causes Control. 2024;35(3):523-9. 10.1007/s10552-023-01812-w.


34. Janjigian YY, Ajani JA, Moehler M, Shen L, Garrido M, Gallardo C, et al. First-Line Nivolumab Plus Chemotherapy for Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: 3-Year Follow-Up of the Phase III CheckMate 649 Trial. J Clin Oncol. 2024:Jco2301601. 10.1200/jco.23.01601.


35. Junior JNA, Preto DD, Lazarini M, de Lima MA, Bonatelli M, Berardinelli GN, et al. PD-L1 expression and microsatellite instability (MSI) in cancer of unknown primary site. Int J Clin Oncol. 2024. 10.1007/s10147-024-02494-3.


36. Laus AC, Gomes INF, da Silva ALV, da Silva LS, Milan MB, AparecidaTeixeira S, et al. Establishment and molecular characterization of HCB-541, a novel and aggressive human cutaneous squamous cell carcinoma cell line. Hum Cell. 2024. 10.1007/s13577-024-01054-1.


37. Matos LL, Kowalski LP, Chaves ALF, de Oliveira TB, Marta GN, Curado MP, et al. Latin American Consensus on the Treatment of Head and Neck Cancer. JCO Glob Oncol. 2024;10:e2300343. 10.1200/go.23.00343.


38. McNeil MJ, Garcia Quintero X, Gonzalez M, Zheng Y, Ugaz Olivares C, Morales R, et al. Preventing and Treating Pain and Anxiety during Needle-Based Procedures in Children with Cancer in Low- and Middle-Income Countries. Cancers (Basel). 2024;16(5). 10.3390/cancers16051025.


39. Monteiro MR, Nunes NCC, Junior A, Fêde ABS, Bretas GO, Souza CP, et al. Antibody-Drug Conjugates in Breast Cancer: A Comprehensive Review of How to Selectively Deliver Payloads. Breast Cancer (Dove Med Press). 2024;16:51-70. 10.2147/bctt.S448191.


40. Oliveira AGS, Rocha MA, de Azevedo LS, Coelho ATM, Chagas RCR, Santos HB, et al. Tapirira guianensis is Selectively Cytotoxic, Induces Apoptosis to the Glioblastoma and Decreases Tumor Growth and Angiogenesis in vivo. Planta Med. 2024;90(1):13-24. 10.1055/a-2181-2569.


41. Paiva BSR, Mingardi M, de Almeida LF, de Camargos MG, Valentino TCO, Julião M, et al. Go Wish card game-exploring end-of-life wishes of patients in oncology palliative care: a qualitative study. Ann Palliat Med. 2024;13(1):31-41. 10.21037/apm-23-381.


42. Paiva CE, Paiva BSR. Challenging Rationality: Examining the Belief in Cure Among Patients With Advanced Incurable Cancers. Oncologist. 2024;29(2):e296-e7. 10.1093/oncolo/oyad284.


43. Paiva CE, Zonta MPM, Granero RC, Guimarães VS, Pimenta LM, Teixeira GR, et al. The Magee 3 Equation Predicts Favorable Pathologic Response to Neoadjuvant Endocrine Therapy in Breast Cancer Patients. Cancers (Basel). 2024;16(2). 10.3390/cancers16020339.


44. Palavani LB, Ferreira MY, Borges P, Bandeira L, da Silva Semione G, Almeida MV, et al. Ultrasound-Guided Resection of High-Grade Gliomas: A Single-Arm Meta-Analysis. World Neurosurg. 2024;186:17-26. 10.1016/j.wneu.2024.03.033.


45. Palavani LB, Silva GM, Borges P, Ferreira MY, Sousa MP, Leite M, et al. Fractionated stereotactic radiotherapy in craniopharyngiomas: A systematic review and single arm meta-analysis. J Neurooncol. 2024. 10.1007/s11060-024-04621-6.


46. Perdomo S, Abedi-Ardekani B, de Carvalho AC, Ferreiro-Iglesias A, Gaborieau V, Cattiaux T, et al. The Mutographs biorepository: A unique genomic resource to study cancer around the world. Cell Genom. 2024:100500. 10.1016/j.xgen.2024.100500.


47. Pereira-Vieira J, Weber DD, Silva S, Barbosa-Matos C, Granja S, Reis RM, et al. Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia. J Pharmaceutics. 2024;16(4):442. 10.3390/pharmaceutics16040442.


48. Pires RC, Gama RR, da Silveira Júnior PS, Teixeira FM, Santos CR, de Castro Capuzzo R. Analysis of durability and replacement of vocal prostheses in total laryngectomy patients at a head and neck surgery referral center. Eur Arch Otorhinolaryngol. 2024;281(1):351-7. 10.1007/s00405-023-08180-w.


49. Pirola WE, Barroso EM, Gama RR, dos Santos Neto MF, Teodoro VA, da Silva Tozzo FCB, et al. Association between periodontal disease and breast cancer: systematic review and meta-analysis. Revista Eletrônica Acervo Saúde. 2024;24(2):e15386-e. 10.25248/reas.e15386.2024.


50. Purdue MP, Dutta D, Machiela MJ, Gorman BR, Winter T, Okuhara D, et al. Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions. Nat Genet. 2024. 10.1038/s41588-024-01725-7.


51. Reis MT, Matsushita M, Santos W, de Lima MA, Guimarães DP, Reis RM. Assessing the applicability and interobserver variability of tumor budding and poorly differentiated clusters in colorectal cancer. Surgical Experimental Pathology. 2024;7(1):1. 10.1186/s42047-024-00144-6.


52. Riedmeier M, Antonini SRR, Brandalise S, Costa T, Daiggi CM, de Figueiredo BC, et al. International consensus on mitotane treatment in pediatric patients with adrenal cortical tumors: indications, therapy, and management of adverse effects. Eur J Endocrinol. 2024;190(4):G15-g24. 10.1093/ejendo/lvae038.


53. Scuglia M, Frazão LP, Miranda A, Martins A, Barbosa-Sequeira J, Coimbra D, et al. Diaphragmatic hernia repair porcine model to compare the performance of biodegradable membranes against Gore-Tex(®). Pediatr Surg Int. 2024;40(1):7. 10.1007/s00383-023-05584-x.


54. Sorroche BP, Miranda KC, Beltrami CM, Arantes L, Kowalski LP, Marchi FA, et al. HOXA1 3’UTR Methylation Is a Potential Prognostic Biomarker in Oral Squamous cell Carcinoma. Cancers (Basel). 2024;16(5). 10.3390/cancers16050874.


55. Stelet VN, Romero M, Cita RF, Binato R, Abdelhay E. A novel HLA-C*02:10 variant, HLA-C*02:10:09, identified in a healthy individual from Brazil. Hla. 2024;103(2):e15410. 10.1111/tan.15410.


56. Straus Takahashi M, Gustavo Ieiri Yamanari M, Henrique de Marqui Moraes P, Iglesias Lopes R, Chammas MC. Vesicoureteral reflux by contrast ultrasound, comparison with voiding and retrograde urethrocystography: A prospective accuracy study. J Pediatr Urol. 2024;20(1):133.e1-.e9. 10.1016/j.jpurol.2023.10.014.


57. Syrjänen K, Eskelinen M, Meklin J, Hendolin P, Eskelinen M, Suovaniemi O. Colorectal Cancer Screening by Fecal Immunochemical Tests (FIT): Considerations on Sampling and Markers (Hb and Hb/Hp Complex) of Fecal Occult Blood (FOB). Anticancer Res. 2024;44(4):1513-23. 10.21873/anticanres.16948.


58. Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, et al. Long-term health-related quality of life in head and neck cancer survivors: A large multinational study. Int J Cancer. 2024. 10.1002/ijc.34861.


59. Teixeira RJ, de Souza VG, Sorroche BP, Paes VG, Zambuzi-Roberto FA, Pereira CAD, et al. Immunohistochemistry assessment of tissue neutrophil-to-lymphocyte ratio (tNLR) predicts outcomes in melanoma patients treated with anti-programmed cell death 1 therapy. Melanoma Res. 2024. 10.1097/cmr.0000000000000958.


60. Trevizan FB, Paiva CE, de Almeida LF, de Oliveira MA, Bruera E, Paiva BSR. When and how to discuss about palliative care and advance care planning with cancer patients: A mixed-methods study. Palliat Support Care. 2024;22(2):387-95. 10.1017/s1478951523001517.


61. Ubinha ACF, Pedrão PG, Tadini AC, Schmidt RL, Santos MHD, Andrade C, et al. The Role of Pelvic Exenteration in Cervical Cancer: A Review of the Literature. Cancers (Basel). 2024;16(4). 10.3390/cancers16040817.


62. Vázquez-Iglesias L, Stanfoca Casagrande GM, García-Lojo D, Ferro Leal L, Ngo TA, Pérez-Juste J, et al. SERS sensing for cancer biomarker: Approaches and directions. Bioact Mater. 2024;34:248-68. 10.1016/j.bioactmat.2023.12.018.


63. Vianna FSL, Neves LL, Testa R, Nassar AP, Jr., Peres JHF, da Silva RÁ J, et al. Impact of the COVID-19 Pandemic on the Outcomes of Patients Undergoing Oncological Surgeries: CORONAL Study. Ann Surg Oncol. 2024. 10.1245/s10434-024-15152-9.


64. Vieira IA, Pezzi EH, Bandeira IC, Reis LB, de Araújo Rocha YM, Fernandes BV, et al. Functional pri-miR-34b/c rs4938723 and KRAS 3’UTR rs61764370 SNPs: Novel phenotype modifiers in Li-Fraumeni Syndrome? Gene. 2024;898:148069. 10.1016/j.gene.2023.148069.


65. Vieira IA, Viola GD, Pezzi EH, Kowalski TW, Fernandes BV, Andreis TF, et al. Exploring the frequency of a TP53 polyadenylation signal variant in tumor DNA from patients diagnosed with lung adenocarcinomas, sarcomas and uterine leiomyomas. Genet Mol Biol. 2024;46(3 Suppl 1):e20230133. 10.1590/1678-4685-gmb-2023-0133.


66. Vieira R, Paulinelli RR, de Oliveira-Junior I. Extreme oncoplasty: past, present and future. Front Oncol. 2024;13:1215284. 10.3389/fonc.2023.1215284.


67. Vieira TDS, Freitas FV, Silva Neto LCB, Borçoi AR, Barbosa WM, Olinda AS, et al. An industrialized diet as a determinant of methylation in the 1F region of the NR3C1 gene promoter. Frontiers in Nutrition. 2024;11:1168715. 10.3389/fnut.2024.1168715.


68. Wang W, Kumm ZT, Ho C, Zanesco-Fontes I, Texiera G, Reis RM, et al. Unsupervised machine learning models reveal predictive clinical markers of glioblastoma patient survival using white blood cell counts prior to initiating chemoradiation. Neurooncol Adv. 2024;6(1):vdad140. 10.1093/noajnl/vdad140.


69. Wood A, Pereira A, Araújo E, Ferigatto J, Buexm L, Barroso E, et al. Evaluation of the Impact of Oral Health on the Daily Activities of Users of the National Health System. Int J Environ Res Public Health. 2024;21(1). 10.3390/ijerph21010092.



Grupos de Pesquisas